IL6 and fatty liver disease: In addition to their reports, our current study raises another possible scenario in which extracellular HCV core protein with the substitution (70Q) enhances IL-6 production and reduces adiponectin production from visceral adipose tissue, leading to insulin resistance, hepatic steatosis, and ultimately the development of HCC.